A new drug for the treatment of narcolepsy and obstructive sleep apnea is coming to market in Germany in the form of Solriamfetol 75mg and 150mg film-coated tablets. Solriamfetol is a psychoanaleptic that inhibits the reuptake of dopamine and noradrenaline.

http://news.gelbe-liste.de/c/33246521/7c295f2a515a1-1fc7bog